These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 23243199)

  • 1. Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity.
    Yu JB; Soulos PR; Herrin J; Cramer LD; Potosky AL; Roberts KB; Gross CP
    J Natl Cancer Inst; 2013 Jan; 105(1):25-32. PubMed ID: 23243199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Proton vs intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity.
    Schild SE; Keole SR; Foote RL
    J Natl Cancer Inst; 2013 May; 105(10):748. PubMed ID: 23559544
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer.
    Pan HY; Jiang J; Hoffman KE; Tang C; Choi SL; Nguyen QN; Frank SJ; Anscher MS; Shih YT; Smith BD
    J Clin Oncol; 2018 Jun; 36(18):1823-1830. PubMed ID: 29561693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity.
    Yu JB; Cramer LD; Herrin J; Soulos PR; Potosky AL; Gross CP
    J Clin Oncol; 2014 Apr; 32(12):1195-201. PubMed ID: 24616315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.
    Fang P; Mick R; Deville C; Both S; Bekelman JE; Christodouleas JP; Guzzo TJ; Tochner Z; Hahn SM; Vapiwala N
    Cancer; 2015 Apr; 121(7):1118-27. PubMed ID: 25423899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protons for prostate cancer: the dream versus the reality.
    Lawrence TS; Feng M
    J Natl Cancer Inst; 2013 Jan; 105(1):7-8. PubMed ID: 23243201
    [No Abstract]   [Full Text] [Related]  

  • 7. Response.
    Yu JB; Soulos PR; Herrin J; Cramer LD; Roberts KB; Gross CP
    J Natl Cancer Inst; 2013 May; 105(10):748-9. PubMed ID: 23814886
    [No Abstract]   [Full Text] [Related]  

  • 8. The body of evidence for advanced technology in radiation oncology.
    Bekelman JE; Hahn SM
    J Natl Cancer Inst; 2013 Jan; 105(1):6-7. PubMed ID: 23243200
    [No Abstract]   [Full Text] [Related]  

  • 9. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.
    Hummel S; Simpson EL; Hemingway P; Stevenson MD; Rees A
    Health Technol Assess; 2010 Oct; 14(47):1-108, iii-iv. PubMed ID: 21029717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
    Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.
    Sheets NC; Goldin GH; Meyer AM; Wu Y; Chang Y; Stürmer T; Holmes JA; Reeve BB; Godley PA; Carpenter WR; Chen RC
    JAMA; 2012 Apr; 307(15):1611-20. PubMed ID: 22511689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Population-Based Study Comparing Treatment-Related Toxicity in Men Who Received Intensity Modulated Versus 3-Dimensional Conformal Radical Radiation Therapy for Prostate Cancer.
    Sujenthiran A; Nossiter J; Charman SC; Parry M; Dasgupta P; van der Meulen J; Cathcart PJ; Clarke NW; Payne H; Aggarwal A
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1253-1260. PubMed ID: 28974414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy, Intensity-modulated Radiotherapy, and Proton Beam Therapy.
    Schroeck FR; Jacobs BL; Bhayani SB; Nguyen PL; Penson D; Hu J
    Eur Urol; 2017 Nov; 72(5):712-735. PubMed ID: 28366513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing Risk for Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer, 2002-2015.
    Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ
    JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of intensity-modulated radiotherapy on acute genitourinary and gastrointestinal toxicity in the treatment of localized prostate cancer.
    Jani AB; Gratzle J; Correa D
    Technol Cancer Res Treat; 2007 Feb; 6(1):11-5. PubMed ID: 17241095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reimbursement and use of intensity-modulated radiation therapy for prostate cancer.
    Shahinian VB; Kaufman SR; Yan P; Herrel LA; Borza T; Hollenbeck BK
    Medicine (Baltimore); 2017 Jun; 96(25):e6929. PubMed ID: 28640073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated Analysis of Comparative Toxicity of Proton and Photon Radiation for Prostate Cancer.
    Yu JB; DeStephano DM; Jeffers B; Horowitz DP; Soulos PR; Gross CP; Cheng SK
    J Clin Oncol; 2024 Jun; 42(16):1943-1952. PubMed ID: 38507655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting.
    Santos PMG; Barsky AR; Hwang WT; Deville C; Wang X; Both S; Bekelman JE; Christodouleas JP; Vapiwala N
    Cancer; 2019 Dec; 125(23):4278-4293. PubMed ID: 31503338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis.
    Dutz A; Agolli L; Baumann M; Troost EGC; Krause M; Hölscher T; Löck S
    Acta Oncol; 2019 Jun; 58(6):916-925. PubMed ID: 30882264
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic genitourinary and gastrointestinal toxicity of prostate cancer patients undergoing pelvic radiotherapy with intensity-modulated versus 4-field technique.
    Su AW; Jani AB
    Am J Clin Oncol; 2007 Jun; 30(3):215-9. PubMed ID: 17551295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.